BNTX:NASDAQ
BioNTech SE - ADR
$85.60
arrow_upward
+0.66%(+0.56) 1D
$85.75
arrow_upward
+0.18% (+0.15)bedtimeAfter hours
Closed: Nov 13, 4:00:01 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for BNTX...
Open
$85.12
High
$86.00
Low
$84.23
Mkt. cap
21.22B
Avg. vol.
1.09M
Volume
844.84K
52-wk high
$124.00
52-wk low
$79.52
EPS
-$6.48
Beta
1.26
Shares outstanding
251.20M
No. of employees
8K
Open
$85.12
High
$86.00
Low
$84.23
Mkt. cap
21.22B
Avg. vol.
1.09M
Volume
844.84K
52-wk high
$124.00
52-wk low
$79.52
EPS
-$6.48
Beta
1.26
Shares outstanding
251.20M
No. of employees
8K
News stories
From web sources and news partners
News Corp
·
13 hours ago
BioNTech May Be the Next Moderna. Even if it Isn’t, the Stock Is a Buy.
Barron's
·
13 hours ago
BioNTech May Be the Next Moderna. Even if it Isn’t, the Stock Is a Buy.
Yahoo! Finance Canada
·
20 hours ago
BioNTech (BNTX) Dropped, So What Is Driving Attention Now?
Profile
BioNTech SE is a German multinational biotechnology company headquartered in Mainz that develops immunotherapies and vaccines, particularly for cancer and infectious diseases.
The company utilizes technology platforms including mRNA-based therapies, targeted therapies, and immunomodulators, to develop its treatments. BioNTech's pipeline includes several late-stage programs in oncology testing combination therapy approaches to improve treatment outcomes.
In the field of infectious diseases, BioNTech, partnering with Pfizer, developed Comirnaty, the first approved mRNA-based vaccine, which was widely used during the COVID-19 pandemic. Wikipedia
About BioNTech SE - ADR